应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
NAVB Navidea生物制药
盘后交易 12-23 16:00:00 EST 延时
盘后
0.0001
+0.0000
0.00%
16:05 EST
资讯
新帖
简况
美国OTC市场Navidea Biopharmaceuticals, Inc.盘中异动 股价大涨100.00%报0.001美元
市场透视 · 11-08
美国OTC市场Navidea Biopharmaceuticals, Inc.盘中异动 股价大涨100.00%报0.001美元
美国OTC市场Navidea Biopharmaceuticals, Inc.股价重挫60.00% 市值跌1.2万美元
市场透视 · 11-06
美国OTC市场Navidea Biopharmaceuticals, Inc.股价重挫60.00% 市值跌1.2万美元
美国OTC市场Navidea Biopharmaceuticals, Inc.股价重挫50.00% 市值跌2.5万美元
市场透视 · 11-04
美国OTC市场Navidea Biopharmaceuticals, Inc.股价重挫50.00% 市值跌2.5万美元
美国OTC市场Navidea Biopharmaceuticals, Inc.盘中异动 下午盘股价大涨40.00%报0.001美元
市场透视 · 09-26
美国OTC市场Navidea Biopharmaceuticals, Inc.盘中异动 下午盘股价大涨40.00%报0.001美元
美国OTC市场Navidea Biopharmaceuticals, Inc.（NAVB.us）盘中异动 股价大跌50.00%
自选股智能写手 · 08-16
美国OTC市场Navidea Biopharmaceuticals, Inc.（NAVB.us）盘中异动 股价大跌50.00%
美国OTC市场Navidea Biopharmaceuticals, Inc.（NAVB.us）股价飙升199900.00% 市值涨4亿美元
自选股智能写手 · 08-14
美国OTC市场Navidea Biopharmaceuticals, Inc.（NAVB.us）股价飙升199900.00% 市值涨4亿美元
美国OTC市场Navidea Biopharmaceuticals, Inc.（NAVB.us）盘中异动 下午盘急速跳水90.00%报0.001美元
自选股智能写手 · 07-17
美国OTC市场Navidea Biopharmaceuticals, Inc.（NAVB.us）盘中异动 下午盘急速跳水90.00%报0.001美元
美国OTC市场Navidea Biopharmaceuticals, Inc.（NAVB.us）股价拉升900.00% 市值涨900.9万美元
自选股智能写手 · 07-15
美国OTC市场Navidea Biopharmaceuticals, Inc.（NAVB.us）股价拉升900.00% 市值涨900.9万美元
Navidea生物制药公司宣布2024年7月2日完成探索性分析结果。
智通财经 · 07-04
Navidea生物制药公司宣布2024年7月2日完成探索性分析结果。
美国OTC市场Navidea Biopharmaceuticals, Inc.（NAVB.us）盘中异动 早盘急速上涨100.00%
自选股智能写手 · 07-02
美国OTC市场Navidea Biopharmaceuticals, Inc.（NAVB.us）盘中异动 早盘急速上涨100.00%
加载更多
公司概况
公司名称：
Navidea生物制药
所属市场：
EXPERT
上市日期：
--
主营业务：
Navidea Biopharmaceuticals, Inc.最初于1983年在俄亥俄州成立，并于1988年重新合并在特拉州。Navidea生物制药有限公司是一家生物制药公司，专注于创新精密的诊断试剂的开发和商业化，旨在提高诊断的准确性，临床决策和病人护理。
发行价格：
--
{"stockData":{"symbol":"NAVB","market":"US","secType":"STK","nameCN":"Navidea生物制药","latestPrice":0.0001,"timestamp":1734987600000,"preClose":0.0001,"halted":0,"volume":117552,"hourTrading":{"tag":"盘后","latestPrice":0.0001,"preClose":0.0001,"latestTime":"16:05 EST","volume":56136,"amount":5.6136,"timestamp":1734987924715},"delay":15,"floatShares":64072382,"shares":99994385,"eps":-0.026045,"marketStatus":"盘后交易","marketStatusCode":4,"change":0,"latestTime":"12-23 16:00:00 EST 延时","open":0.0001,"high":0.0001,"low":0.0001,"amount":11.755199999999999,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.026045,"exchange":"EXPERT","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1735002000000},"adr":0,"adjPreClose":0.0001,"volumeRatio":5.599741},"requestUrl":"/m/hq/s/NAVB","defaultTab":"news","newsList":[{"id":"2481488293","title":"美国OTC市场Navidea Biopharmaceuticals, Inc.盘中异动 股价大涨100.00%报0.001美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481488293","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481488293?lang=zh_cn&edition=full","pubTime":"2024-11-08 23:44","pubTimestamp":1731080664,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日23时44分，美国OTC市场Navidea Biopharmaceuticals, Inc.股票出现波动，股价急速拉升100.00%。截至发稿，该股报0.001美元/股，成交量1235股，换手率0.00%，振幅0.00%。美国OTC市场Navidea Biopharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.99%。美国OTC市场Navidea Biopharmaceuticals, Inc.公司简介：Navidea Biopharmaceuticals Inc是一家专注于精准医学的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110823442498e41855&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110823442498e41855&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NAVB"],"gpt_icon":0},{"id":"2481824696","title":"美国OTC市场Navidea Biopharmaceuticals, Inc.股价重挫60.00% 市值跌1.2万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481824696","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481824696?lang=zh_cn&edition=full","pubTime":"2024-11-06 00:23","pubTimestamp":1730823781,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日00时23分，美国OTC市场Navidea Biopharmaceuticals, Inc.股票出现波动，股价大幅下跌60.00%。美国OTC市场Navidea Biopharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.95%。美国OTC市场Navidea Biopharmaceuticals, Inc.公司简介：Navidea Biopharmaceuticals Inc是一家专注于精准医学的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110600230195bdd33c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110600230195bdd33c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NAVB","BK4139"],"gpt_icon":0},{"id":"2480840595","title":"美国OTC市场Navidea Biopharmaceuticals, Inc.股价重挫50.00% 市值跌2.5万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480840595","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480840595?lang=zh_cn&edition=full","pubTime":"2024-11-04 22:48","pubTimestamp":1730731682,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日22时48分，美国OTC市场Navidea Biopharmaceuticals, Inc.股票出现异动，股价大幅下跌50.00%。美国OTC市场Navidea Biopharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.15%。其相关个股中，Disc Medicine, Inc.、Neurogene Inc.、Tenaya Therapeutics, Inc.涨幅较大，Nls Pharmaceutics Ltd.、Elevai Labs, Inc.、Gri Bio, Inc.较为活跃，换手率分别为252.59%、161.73%、53.43%，振幅较大的相关个股有Briacell Therapeutics Corp C/Wts 24/02/2025、Nls Pharmaceutics Ltd.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为29.83%、25.56%、22.67%。美国OTC市场Navidea Biopharmaceuticals, Inc.公司简介：Navidea Biopharmaceuticals Inc是一家专注于精准医学的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110422480395bdca73&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110422480395bdca73&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NAVB","BK4139"],"gpt_icon":0},{"id":"2470129733","title":"美国OTC市场Navidea Biopharmaceuticals, Inc.盘中异动 下午盘股价大涨40.00%报0.001美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470129733","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470129733?lang=zh_cn&edition=full","pubTime":"2024-09-26 03:12","pubTimestamp":1727291521,"startTime":"0","endTime":"0","summary":"北京时间2024年09月26日03时12分，美国OTC市场Navidea Biopharmaceuticals, Inc.股票出现异动，股价快速上涨40.00%。截至发稿，该股报0.001美元/股，成交量3343股，换手率0.00%，振幅40.00%。美国OTC市场Navidea Biopharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.44%。美国OTC市场Navidea Biopharmaceuticals, Inc.公司简介：Navidea Biopharmaceuticals Inc是一家专注于精准医学的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240926031201957d8943&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240926031201957d8943&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NAVB"],"gpt_icon":0},{"id":"2459408992","title":"美国OTC市场Navidea Biopharmaceuticals, Inc.（NAVB.us）盘中异动 股价大跌50.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459408992","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459408992?lang=zh_cn&edition=full","pubTime":"2024-08-16 01:00","pubTimestamp":1723741201,"startTime":"0","endTime":"0","summary":"北京时间2024年08月16日01时00分，美国OTC市场Navidea Biopharmaceuticals, Inc.股票出现异动，股价快速下跌50.00%。美国OTC市场Navidea Biopharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.36%。其相关个股中，Cingulate Inc.、Nutriband Inc C/Wts 、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Cingulate Inc.、Scisparc Ltd.、Altamira Therapeutics Ltd.较为活跃，换手率分别为8250.87%、2260.17%、623.57%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Nutriband Inc C/Wts 、Seastar Medical Holding Corp C/Wts 28/10/2027 ，振幅分别为163.00%、115.79%、103.98%。美国OTC市场Navidea Biopharmaceuticals, Inc.公司简介：Navidea Biopharmaceuticals Inc是一家专注于精准医学的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408160100019f2e64d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408160100019f2e64d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NAVB"],"gpt_icon":0},{"id":"2459817020","title":"美国OTC市场Navidea Biopharmaceuticals, Inc.（NAVB.us）股价飙升199900.00% 市值涨4亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459817020","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459817020?lang=zh_cn&edition=full","pubTime":"2024-08-14 22:16","pubTimestamp":1723644961,"startTime":"0","endTime":"0","summary":"北京时间2024年08月14日22时16分，美国OTC市场Navidea Biopharmaceuticals, Inc.股票出现异动，股价快速拉升199900.00%。美国OTC市场Navidea Biopharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.16%。其相关个股中，Newamsterdam Pharma Co Nv C/Wts 、Conduit Pharmaceuticals Inc.、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Genprex, Inc.、Conduit Pharmaceuticals Inc.、Viracta Therapeutics, Inc.较为活跃，换手率分别为83.05%、66.10%、48.54%，振幅较大的相关个股有Seastar Medical Holding Corp C/Wts 28/10/2027 、Genprex, Inc.、Tc Biopharm Plc，振幅分别为60.83%、58.52%、49.86%。美国OTC市场Navidea Biopharmaceuticals, Inc.公司简介：Navidea Biopharmaceuticals Inc是一家专注于精准医学的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408142216019f2ad74e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408142216019f2ad74e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NAVB","BK4139"],"gpt_icon":0},{"id":"2452949248","title":"美国OTC市场Navidea Biopharmaceuticals, Inc.（NAVB.us）盘中异动 下午盘急速跳水90.00%报0.001美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452949248","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452949248?lang=zh_cn&edition=full","pubTime":"2024-07-17 02:30","pubTimestamp":1721154602,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日02时30分，美国OTC市场Navidea Biopharmaceuticals, Inc.股票出现波动，股价急速下跌90.00%。截至发稿，该股报0.001美元/股，成交量3083股，换手率0.00%，振幅0.00%。美国OTC市场Navidea Biopharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.10%。美国OTC市场Navidea Biopharmaceuticals, Inc.公司简介：Navidea Biopharmaceuticals Inc是一家专注于精准医学的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407170230029f57d0e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407170230029f57d0e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NAVB"],"gpt_icon":0},{"id":"2451624910","title":"美国OTC市场Navidea Biopharmaceuticals, Inc.（NAVB.us）股价拉升900.00% 市值涨900.9万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451624910","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2451624910?lang=zh_cn&edition=full","pubTime":"2024-07-15 23:26","pubTimestamp":1721057161,"startTime":"0","endTime":"0","summary":"北京时间2024年07月15日23时26分，美国OTC市场Navidea Biopharmaceuticals, Inc.股票出现异动，股价大幅拉升900.00%。截至发稿，该股报0.010美元/股，成交量5229股，换手率0.01%，振幅900.00%。美国OTC市场Navidea Biopharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。美国OTC市场Navidea Biopharmaceuticals, Inc.公司简介：Navidea Biopharmaceuticals Inc是一家专注于精准医学的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071523260195c12693&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071523260195c12693&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NAVB","BK4139"],"gpt_icon":0},{"id":"2448437448","title":"Navidea生物制药公司宣布2024年7月2日完成探索性分析结果。","url":"https://stock-news.laohu8.com/highlight/detail?id=2448437448","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448437448?lang=zh_cn&edition=full","pubTime":"2024-07-04 04:30","pubTimestamp":1720038607,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","NAVB"],"gpt_icon":0},{"id":"2448016837","title":"美国OTC市场Navidea Biopharmaceuticals, Inc.（NAVB.us）盘中异动 早盘急速上涨100.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448016837","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448016837?lang=zh_cn&edition=full","pubTime":"2024-07-02 22:30","pubTimestamp":1719930603,"startTime":"0","endTime":"0","summary":"北京时间2024年07月02日22时30分，美国OTC市场Navidea Biopharmaceuticals, Inc.股票出现波动，股价急速上涨100.00%。美国OTC市场Navidea Biopharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.09%。其相关个股中，Zura Bio Limited C/Wts 、Moolec Science Sa C/Wts 、Revelation Biosciences Inc C/Wts 10/01/2027 涨幅较大，Gri Bio, Inc.、Geovax Labs, Inc.、Mustang Bio, Inc.较为活跃，换手率分别为44.64%、29.84%、24.56%，振幅较大的相关个股有Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Anew Medical Inc C/Wts 21/06/2029 、Revelation Biosciences Inc C/Wts 10/01/2027 ，振幅分别为72.83%、39.76%、39.00%。美国OTC市场Navidea Biopharmaceuticals, Inc.公司简介：Navidea Biopharmaceuticals Inc是一家专注于精准医学的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407022230039ef5048f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407022230039ef5048f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NAVB","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.navidea.com","description":"Navidea Biopharmaceuticals, Inc.最初于1983年在俄亥俄州成立，并于1988年重新合并在特拉州。Navidea生物制药有限公司是一家生物制药公司，专注于创新精密的诊断试剂的开发和商业化，旨在提高诊断的准确性，临床决策和病人护理。","exchange":"EXPERT","name":"Navidea生物制药","nameEN":"Navidea Biopharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Navidea生物制药(NAVB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Navidea生物制药(NAVB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Navidea生物制药,NAVB,Navidea生物制药股票,Navidea生物制药股票老虎,Navidea生物制药股票老虎国际,Navidea生物制药行情,Navidea生物制药股票行情,Navidea生物制药股价,Navidea生物制药股市,Navidea生物制药股票价格,Navidea生物制药股票交易,Navidea生物制药股票购买,Navidea生物制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Navidea生物制药(NAVB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Navidea生物制药(NAVB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}